Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Use of substituted or modified C60 fullerenes for the prevention or treatment of thrombosis, peripheral arterial occlusion, and catheter obstruction. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jan 2011 - 11 pages - $500
Mar 2011 - 6 pages - $500
Mar 2010 - 414 pages - $690
Apr 2011 - 86 pages - $3,835
Feb 2009 - 242 pages - $690
Nov 2010 - 330 pages - $1,495
Apr 2010 - 5 pages - $500
Nov 2009 - 25 pages - $1,000
Nov 2010 - 40 pages - $500
Jan 2011 - 38 pages - $515
Your selection
Browse By
- Industry sector
- Adhesives
- Coatings
- Films
- Resins
- Therapeutic target
- Blood disorders (other)
- Hemolytic uremic syndrome
- Hemophilia
- Myelodysplastic syndrome
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us